Zdrowie i gospodarka · 23/11/2020

FDA Releases Draft Guidance for Industry on Clinical Drug Interaction Studies With Combined Oral Contraceptives

The Food and Drug Administration (FDA) has published a draft guidance to help pharmaceutical companies evaluate the potential for drug interactions with combined oral contraceptives during the development of new medications, and to communicate the results of these studies.